Thomason Lynn C, Costantino Nina, Shaw Dana V, Court Donald L
Gene Regulation and Chromosome Biology Laboratory, Building 539, Room 243, National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Plasmid. 2007 Sep;58(2):148-58. doi: 10.1016/j.plasmid.2007.03.001. Epub 2007 Apr 16.
Recombineering, in vivo genetic engineering using the bacteriophage lambda Red generalized recombination system, was used to create various modifications of a multicopy plasmid derived from pBR322. All genetic modifications possible on the Escherichia coli chromosome and on bacterial artificial chromosomes (BACs) are also possible on multicopy plasmids and are obtained with similar frequencies to their chromosomal counterparts, including creation of point mutations (5-10% unselected frequency), deletions and substitutions. Parental and recombinant plasmids are nearly always present as a mixture following recombination, and circular multimeric plasmid molecules are often generated during the recombineering.
重组工程是利用噬菌体λ Red 广义重组系统进行的体内基因工程,用于对源自pBR322的多拷贝质粒进行各种修饰。在大肠杆菌染色体和细菌人工染色体(BAC)上可能进行的所有基因修饰,在多拷贝质粒上也都可行,并且获得的频率与其染色体对应物相似,包括产生点突变(未选择频率为5 - 10%)、缺失和替换。重组后,亲本质粒和重组质粒几乎总是以混合物形式存在,并且在重组工程过程中经常会产生环状多聚体质粒分子。